---
name: Management of Unspecified Histologic HSIL and Negative Surveillance in Those Who Are Concerned About the Potential Effect of Treatment on Future Pregnancy Outcomes I3.3

externalData:
- resources

data:
- 
  resourceType: Patient
  name: Joanne Smith
  gender: female
  birthDate: 1991-01-01
  extension:
  -
    url: http://hl7.org/fhir/us/core/StructureDefinition/us-core-birthsex
    valueCode: F
- 
  resourceType: DiagnosticReport
  code: LOINC#65753-6 Cervix Pathology biopsy report
  status: final
  conclusionCode:
  - SNOMEDCT#22725004 High-grade squamous intraepithelial lesion (morphologic abnormality)
  effectiveDateTime: 2019-09-01
- 
  resourceType: DiagnosticReport
  code: LOINC#65753-6 Cervix Pathology biopsy report
  status: final
  conclusionCode:
  - SNOMEDCT#373887005 Negative for intraepithelial lesion or malignancy (finding)
  effectiveDateTime: 2020-05-01
- 
  resourceType: DiagnosticReport
  code: LOINC#65753-6 Cervix Pathology biopsy report
  status: final
  conclusionCode:
  - SNOMEDCT#373887005 Negative for intraepithelial lesion or malignancy (finding)
  effectiveDateTime: 2021-05-01
- 
  resourceType: Observation
  code: http://OUR-PLACEHOLDER-URL.com#FPCQ Does the patient have future pregnancy concerns related to treatment options?
  status: final
  valueCodeableConcept: SNOMEDCT#373066001 Yes (qualifier value)
  effectiveDateTime: 2021-05-23

results:
  IsIncludedAndNotExcluded: true
  RareAbnormalityRecommendation: 
    action: 'ManagementHistologyI3.3'
    text: 'Subsequent surveillance with colposcopy and HPV-based testing should occur every year since the patient has demonstrated less than CIN2 and less than ASC-H during surveillance following a histologic unspecified or CIN2 result.'